Pictet Asset Management (Switzerland)’s SpringWorks Therapeutics SWTX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$27.8M	Sell	1,061,538 -31,812	-3%	-$836K	0.03%	390
2023 Q1	$28.1M	Buy	1,093,350 +6,783	+0.6%	+$198K	0.04%	387
2022 Q4	$28.3M	Sell	1,086,567 -18,973	-2%	-$467K	0.04%	369
2022 Q3	$31.5M	Buy	1,105,540 +1,963	+0.2%	+$56.3K	0.05%	344
2022 Q2	$27.2M	Buy	1,103,577 +470,129	+74%	+$17.2M	0.04%	395
2022 Q1	$35.8M	Sell	633,448 -60,207	-9%	-$3.45M	0.04%	379
2021 Q4	$43M	Buy	693,655 +325,706	+89%	+$21.6M	0.04%	369
2021 Q3	$23.3M	Buy	+367,949	New	+$28.4M	0.03%	478

Other funds holding SWTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s SWTX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its SpringWorks Therapeutics (SWTX) stake by 2.9% in Q2 2023, selling an estimated $836K and leaving 1,061,538 shares worth $27.8M. The position accounts for 0.03% of the portfolio, ranked #390.

Pictet Asset Management (Switzerland) first reported a position in SWTX in Q3 2021 and has held it in 8 quarters since. The position peaked at $43M in Q4 2021. 142 funds tracked by Wall St. Rank hold SWTX as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,061,538 shares of SpringWorks Therapeutics worth $27.8M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 31,812 SpringWorks Therapeutics shares in Q2 2023, an estimated $836K.
SpringWorks Therapeutics made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #390 holding.
Pictet Asset Management (Switzerland) first reported a position in SpringWorks Therapeutics in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s SpringWorks Therapeutics position peaked at $43M in Q4 2021.
142 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.